To view this email as a web page, click here.

You are subscribed to the FormularyWatch eNews.

FormularyWatch

Share

eNews Subscribe

More Subscriptions

FORMULARY WATCH

DRUG PRICING

TODAY'S HEADLINES

Diabetic patients challenge insulin makers

In the latest flap over the high cost of drugs, diabetes patients filed a class-action lawsuit against insulin makers. Find out why

Major allergic reactions linked to common antiseptics

FDA is warning about rare but serious allergic reactions to widely used skin antiseptic products containing chlorhexidine gluconate. Read more

CONTINUING PHARMACY EDUCATION

New options when statins are not enough

This month's CE activity, "New options when statins are not enough," is open for pharmacists and pharmacy technicians.
The goal of this activity is to prepare pharmacists with the knowledge they need to have to provide contemporary pharmacologic therapy to patients with hyperlipidemia.
Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

Will Trump's FDA picks speed drug approvals?

As consumers, lawmakers and health organizations become increasingly concerned about high drug prices, three candidates whom President Trump is considering for FDA commissioner are likely to speed drug approvals, potentially lowering drug costs. Read more

February 8, 2017

Managed Care Pharmacy Survey 2017

Take three minutes to answer our managed care pharmacy survey. As a thank-you to survey-takers, when the survey closes, we will hold a drawing to give away not one, but two $200 Visa gift cards. Take survey.

Related Articles

Drugmaker pays out millions over EpiPen charges

FDA issues warning over anesthesia, diabetes drugs

Click to contact the editorial team. Click to contact the sales team.

Part of the

ModernMedicine logo

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply.
Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

 

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Contact Us